NIH-funded research R01 grant

Advancing pharmacy-based delivery of STI and HIV prevention for cisgender women

Official title: Advancing pharmacy-based delivery of primary STI and HIV prevention for cisgender women

Funded at University of Washington · NIH-11478494 · Data updated 2026-11-12

A study in Kenya and similar settings explores using pharmacies to deliver STI prevention and HIV prevention tools to young cisgender women.

More HIV Prevention research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 5, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$459,175
NIH project number3R01HD118713-02S1
Project IDNIH-11478494 on NIH RePORTER

Who could benefit from this research

Could help

Cisgender adolescent girls and young women in Kenya and similar settings who seek contraception or HIV prevention services at pharmacies.

Less likely to help

Individuals not using pharmacies for reproductive health services or those outside the target setting may not benefit.

What this research studies

This project plans to bring STI testing and HIV prevention options to AGYW who seek contraception at community pharmacies, aiming to expand access beyond clinics. It builds on prior work showing high acceptance of STI testing and expedited partner therapy at pharmacies and suggests offering HIV PEP/PrEP through these outlets. The study will use pharmacy-based workflows, qualitative insights, and pilot implementation strategies to assess feasibility, adherence, and potential social harms. If successful, it could enable wider, friendlier access to STI care and HIV prevention for this high-risk group.

Why it matters

Potential benefit: If successful, patients could receive easier access to STI testing and HIV prevention services through local pharmacies.

How similar studies have gone: Preliminary data from ongoing pharmacy-based STI testing and expedited partner therapy show high acceptance among AGYW.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Pintye, Jillian — University of Washington
  • Study coordinator: Pintye, Jillian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.